BioSpace News Archive

Four Clinical Trial Sites Added Across Multiple Clinical Programs, Including Great Ormond Street Hospital, Children’s Hospital of Philadelphia, University of Minnesota and University of California, Los Angeles

Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that two abstracts will be presented at the North American Cystic Fibrosis Conference (NACFC) to be held virtually starting on October 7, 2020. The two abstracts w

Cure SMA and Cytokinetics (Nasdaq:CYTK) today announced the renewal of their partnership to increase education, awareness, public policy and fundraising for spinal muscular atrophy (SMA). Cytokinetics will lend support for several of Cure SMA’s upcoming initiatives across the United States and continues as a member of the Cure SMA Industry Collaboration, a partnership between Cure SMA and pharmaceutical

Kinnate Biopharma Inc., a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically-defined cancers, today announced that it has raised $98 million in a Series C financing. The financing was led b

Data supports a differentiated gp96-based COVID-19 vaccine that induces systemic and tissue-specific (lung) memory CD8+ T cells Gp96-based vaccine generates tissue-resident memory CD8+ T cells that may be instrumental in eradicating SARS-CoV-2 infected cells Tissue specific memory CD8+ T cells potentially important for compromised patient populations

Columbus Citizens Foundation (CCF) is proud to announce a new scholarship to support Italian Americans with great academic prowess seeking financial aid at the graduate level in medical and public health fields of study.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company achieved a $20 million milestone payment from Roche under its License and Collaboration Agreement. The milestone payment was triggered by the first commercial sale of Evrysdi™ (risdiplam) in the U.S. Evrysdi™ was approved by the Food and Drug Admini

Nationwide recruitment underway for up to 30,000 volunteers to receive the vaccine developed by Oxford University and AstraZeneca [26-August-2020] LOS ANGELES , Aug. 26, 2020 /PRNewswire/ -- The Lundquist Institute at Harbor-UCLA Medical Center and UCLA Medical Center in Westwood will soon begin recruiting volunteers for phase 3 trials of a new investigational COVID

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the company has initiated the tooling production for the improved cartridge in its RAP device.

Silverback Therapeutics (“Silverback”), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered but locally active, today announced initiation of a Phase 1 clinical study of SBT6050, a novel therapeutic comprising a specific small molecule toll-like receptor 8 (TLR8) agonist conjugated to a HER2-directed monoclonal antibody. TLR8 is highly expressed in myeloid cells that are prevalent